ARCT May 2024 25.000 call
| Previous close | 5.8000 |
| Open | 5.0000 |
| Bid | 4.8000 |
| Ask | 6.9000 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 4.7000 - 5.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 260 |
Business WireArcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
SAN DIEGO, May 15, 2024--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor and scientific conferences:
Insider MonkeyArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024 Arcturus Therapeutics Holdings Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to the Arcturus Therapeutics First Quarter 2024 Earnings […]
Simply Wall St.Arcturus Therapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) First Quarter 2024 Results Key Financial Results Revenue: US$38.0m (down...
